14 Month Topical Fin/Min .1%/10% + microneedling update
    Finasteride/Dutasteride 1/7/2025

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Finasteride (topical) 0.1% 14 months
    💧 Minoxidil (topical) 10% 14 months
    💧 Dutasteride (topical) 0.1% 1x weekly 2 months
    💧 Latanoprost (topical) 0.01% daily 2 months
    Microneedling 14 months
    💊 MSM supplements (oral) recently added
    the tone is frustrated with some growth results.

    Other terms

    The user reports progress in hair regrowth using topical finasteride/minoxidil, microneedling, topical dutasteride, latanoprost, and MSM supplements. They express frustration over the lack of interaction on progress posts compared to trivial topics.
    View this post in the Community →

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      A Decade of Progress in Androgenetic Alopecia Management: Emerging Therapies and Multimodal Strategies

      research A Decade of Progress in Androgenetic Alopecia Management: Emerging Therapies and Multimodal Strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      Over the past decade, the management of androgenetic alopecia (AGA) has evolved to include integrated, multimodal strategies that address its multifactorial nature. Traditional therapies like minoxidil and finasteride remain foundational, but combination regimens, including emerging treatments such as topical antiandrogens, JAK inhibitors, and regenerative strategies like platelet-rich plasma (PRP) and stem cell-derived exosomes, show promise. Nutraceuticals, botanical supplements, and cosmeceutical peptides offer supportive benefits, while device-based interventions like low-level laser therapy and microneedling stimulate follicular activity. The treatment paradigm is shifting towards personalized regimens, with future directions focusing on biologics, exosomes, and tissue engineering. Despite promising innovations, long-term efficacy data are limited, and many findings are based on small studies or preclinical research.
      Androgenetic Alopecia: An Update Of Treatment Options

      research Androgenetic Alopecia: An Update Of Treatment Options

      110 citations , August 2016 in “Drugs”
      Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

      research Noninvasive Hair Rejuvenation

      May 2023 in “Clinics in Plastic Surgery”
      Noninvasive treatments like PRP and laser therapy can effectively promote hair growth and reduce hair loss.